Monfaredan, A.; Şen, S.; Fathi, N.K.; Taştekin, D.; Hosseininasab, A.; Bozbey, H.U.; Öncül, O.
Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model. Int. J. Mol. Sci. 2025, 26, 8448.
https://doi.org/10.3390/ijms26178448
AMA Style
Monfaredan A, Şen S, Fathi NK, Taştekin D, Hosseininasab A, Bozbey HU, Öncül O.
Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model. International Journal of Molecular Sciences. 2025; 26(17):8448.
https://doi.org/10.3390/ijms26178448
Chicago/Turabian Style
Monfaredan, Amir, Sena Şen, Nahideh Karimian Fathi, Didem Taştekin, Alaviyehsadat Hosseininasab, Hamza Uğur Bozbey, and Oral Öncül.
2025. "Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model" International Journal of Molecular Sciences 26, no. 17: 8448.
https://doi.org/10.3390/ijms26178448
APA Style
Monfaredan, A., Şen, S., Fathi, N. K., Taştekin, D., Hosseininasab, A., Bozbey, H. U., & Öncül, O.
(2025). Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model. International Journal of Molecular Sciences, 26(17), 8448.
https://doi.org/10.3390/ijms26178448
